Intelligent Information to accelerate Research, Scientific Discovery and Innovation

Drug Reports from Cortellis for Competitive Intelligence

Cortellis for Competitive Intelligence - Drug ReportsThomson Reuters Cortellis for Competitive Intelligence is an intuitive intelligence tool with access to a huge database of drug pipelines, deals, patents, companies, and the latest industry news. Learn more by previewing sample drug reports and sign-up for a free two week trial.

Over 40,000 drug reports are available in Thomson Reuters Cortellis for Competitive Intelligence, such as Erlotinib (Tarceva), Etanercept (Enbrel), Imatinib (Gleevec), Infliximab (Remicade) and Pregabalin (Lyrica).

Special Topic of Supersymmetry

st-supersymmetrySince the 1980s, if not earlier, supersymmetry has reigned as the best available candidate for physics beyond the standard model's theory of almost everything that would unite the weak, strong, and electromagnetic interactions in one global formulation, while predicting an entire universe of as-yet-undiscovered elementary particles. In this analysis, ScienceWatch Special Topics examines the literature on supersymmetry over the past decade and over the past two years. Learn more about the Special Topic of supersymmetry...

Latest Press Releases

Join our partner program

Learn more about how to become a partner and our partnership categories.

Master Journal List


Search over 16,000 journal titles covered in our scientific products.

Global Sites